Paul H. Klingenstein, Director at EnteroMedics Inc (ETRM), bought 25,000 shares at $4.50 ($113K) on 2008-05-23, disclosed to the SEC on 2008-05-28.
Open-market purchase of $112k ETRM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CLVS | BUY | 2012-03-22 | $5.2M | — | Filing → |
| ANAC | BUY | 2010-12-01 | $1.5M | — | Filing → |
| ETRM | BUY | 2009-02-25 | $1.4M | — | Filing → |